Risk of cancer among women with polycystic ovary syndrome: A Danish cohort study

Gynecologic Oncology

Volumn 136, Issue 1, 2015, Pages 99-103

  Gottschau, Mathilde ^a   Kjaer, Susanne Krüger ^a,b   Jensen, Allan ^a   Munk, Christian ^a   Mellemkjaer, Lene ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

All cancer sites; Breast cancer; Cohort study; Endometrial cancer; Ovarian cancer; Polycystic ovary syndrome

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRAIN CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CHILD; COHORT ANALYSIS; COLON CANCER; ENDOMETRIUM CANCER; FEMALE; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; OUTPATIENT; OVARY CANCER; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; STANDARDIZED INCIDENCE RATIO; BREAST NEOPLASMS; DENMARK; ENDOMETRIAL NEOPLASMS; MIDDLE AGED; OVARIAN NEOPLASMS; POLYCYSTIC OVARY SYNDROME; REGISTER; YOUNG ADULT;

ADOLESCENT; ADULT; BREAST NEOPLASMS; CHILD; COHORT STUDIES; DENMARK; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; POLYCYSTIC OVARY SYNDROME; REGISTRIES; YOUNG ADULT;

EID: 84925230532     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.11.012     Document Type: Article

References (39)

1. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005;352:1223-36.
2. Fauser BCJM, Tarlatzis BC. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81(1):19-25.
3. Fauser BCJM, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 2012;97(1):28-38.e25.
4. Lauritsen MP, Bentzen JG, Pinborg A, Loft A, Forman JL, Thuesen LL, et al. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Müllerian hormone. Hum Reprod 2014;29(4):791-801.
5. Eilertsen TB, Vanky E, Carlsen SM. Anti-Müllerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced? Hum Reprod 2012;27(8):2494-502.
6. March WA, Moore VM, Willson KJ, Phillips DIW, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010;25(2):544-51.
7. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371(9612):569-78.
8. World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Report. Food, Nutrition, Physical Activity, and the Prevention of Breast Cancer; 2010.
9. World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Report. Food, Nutrition, Physical Activity, and the Prevention of Ovarian Cancer; 2014.
10. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet 2005;366(9484):491-505.
11. Barry JA, Azizia MM, Hardiman PJ. Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 2014:1-11.
12. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011;39(7 Suppl.):30-3.
13. Bronstein J, Tawdekar S, Liu Y, Pawelczak M, David R, Shah B. Age of onset of polycystic ovarian syndrome in girls may be earlier than previously thought. J Pediatr Adolesc Gynecol 2011;24(1):15-20.
14. Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health 2011;39(7 Suppl.):42-5.
15. Bailar JC, Ederer F. 202. Note: significance factors for the ratio of a poisson variable to its expectation. Biometrics 1964;20(3):639-43.
16. Breslow N, Day N. Rates and rate standardization. Statistical Methods in Cancer Research. The design and analysis of cohort studies (IARC Scientific Publications No 82) Lyon: International Agency for Research on Cancer; 1987. p. 48-79.
17. World Cancer Research Fund/American Institute for Cancer Research. Body fatness. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington DC: AICR; 2007. p. 211-28.
18. Evans T, Sany O, Pearmain P, Ganesan R, Blann A, Sundar S. Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006. Br J Cancer 2011;104(9):1505-10.
19. Escobedo LG, Lee NC, Peterson HB, Wingo PA. Infertility-associated endometrial cancer risk may be limited to specific subgroups of infertile women. Obstet Gynecol 1991;77(1):124-8.
20. Niwa K, Imai A, Hashimoto M, Yokoyama Y, Mori H, Matsuda Y, et al. A case-control study of uterine endometrial cancer of pre- and post-menopausal women. Oncol Rep 2000;7(1):89-93.
21. Fearnley EJ, Marquart L, Spurdle AB, Weinstein P, Webb PM. Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study. Cancer Causes Control 2010;21(12):2303-8.
22. Iatrakis G, Zervoudis S, Saviolakis A, Troulos M, Antoniou E, Sarantaki A, et al. Women younger than 50 years with endometrial cancer. Eur J Gynaecol Oncol 2006;27(4):399-400.
23. Zucchetto A, Serraino D, Polesel J, Negri E, De Paoli A, Dal Maso L, et al. Hormone-related factors and gynecological conditions in relation to endometrial cancer risk. Eur J Cancer Prev 2009;18(4):316-21.
24. Lunde O, Tanbo T. Polycystic ovary syndrome: a follow-up study on diabetes mellitus, cardiovascular disease and malignancy 15-25 years after ovarian wedge resection. Gynecol Endocrinol 2007;23(12):704-9.
25. Wild S, Pierpoint T, Jacobs H, McKeigue P. Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study. Hum Fertil 2000;3(2):101-5.
26. Holm NSL, Glintborg D, Andersen MS, Schledermann D, Ravn P. The prevalence of endometrial hyperplasia and endometrial cancer in women with polycystic ovary syndrome or hyperandrogenism. Acta Obstet Gynecol Scand 2012;91(10):1173-6.
27. Clausen HV, Greisen S, Ingemanssen J, Knudsen B, Lindhard A, Mikkelsen A, et al. Polycystic ovary syndrom (PCOS) [Danish]; 2011 1-26[Available from: http://dsog.dk/wp/wp-content/uploads/2013/02/PCOS-rev2014.pdf].
28. Talamini R, Franceschi S, Favero A, Negri E, Parazzini F, La Vecchia C. Selected medical conditions and risk of breast cancer. Br J Cancer 1997;75(11):1699-703.
29. Ghasemi N, Mortazavizadeh MR, Gerdekoohi AK. Frequency of poly cystic ovary syndrome in patients with premenopausal breast cancer. Iran J Reprod Med 2010;8(2):86-9.
30. Anderson KE, Sellers TA, Chen PL, Rich SS, Hong CP, Folsom AR. Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa. Cancer 1997;79(3):494-9.
31. Schildkraut J, Schwingl P, Bastos E, Evanoff A, Hughes C. Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol 1996;88(4):554-9.
32. Olsen CM, Green AC, Nagle CM, Jordan SJ, Whiteman DC, Bain CJ, et al. Epithelial ovarian cancer: testing the "androgens hypothesis". Endocr Relat Cancer 2008;15(4):1061-8.
33. Bodmer M, Becker C, Meier C, Jick SS, Meier CR. Use of metformin and the risk of ovarian cancer: a case-control analysis. Gynecol Oncol 2011;123(2):200-4.
34. Liao C-C, Lin S-Y, Lin H-W, Chen K-H, Chang L-H, Chen S-T, et al. Menstrual abnormalities in a woman with ACTH-dependent pituitary macroadenoma mimicking polycystic ovary syndrome. Taiwan J Obstet Gynecol Jun 2006;45(2):176-9.
35. Yavasoglu I, Kucuk M, Coskun A, Guney E, Kadikoylu G, Bolaman Z. Polycystic Ovary Syndrome and Prolactinoma Association. Intern Med 2009;48(8):611-3.
36. Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935;29:181-91.
37. Azziz R. PCOS: a diagnostic challenge. Reprod Biomed Online 2004;8(6):644-8.
38. Broekmans FJ, Knauff EAH, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BCJM. PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG 2006;113(10):1210-7.
39. Kristensen SL, Ramlau-Hansen CH, Ernst E, Olsen SF, Bonde JP, Vested A, et al. A very large proportion of young Danish women have polycystic ovaries: is a revision of the Rotterdam criteria needed? Hum Reprod 2010;25(12):3117-22.